Protocol No
NEPH-SAAD-IMAGINE
Phase
III
Summary
This project is being done to determine the safety and effectiveness of clazakizumab in patients with CABMR
Description
Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov